- Home
- ZYME vs CCEC Comparison
ZYME vs CCEC Comparison
Compare ZYME & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- CCEC
- Stock Information
- Founded
- ZYME 2003
- CCEC 2007
- Country
- ZYME United States
- CCEC Greece
- Employees
- ZYME N/A
- CCEC N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- CCEC Marine Transportation
- Sector
- ZYME Health Care
- CCEC Consumer Discretionary
- Exchange
- ZYME Nasdaq
- CCEC Nasdaq
- Market Cap
- ZYME 1.2B
- CCEC 1.3B
- IPO Year
- ZYME 2017
- CCEC 2007
- Fundamental
- Price
- ZYME $16.56
- CCEC $22.70
- Analyst Decision
- ZYME Buy
- CCEC Buy
- Analyst Count
- ZYME 7
- CCEC 1
- Target Price
- ZYME $20.00
- CCEC $26.00
- AVG Volume (30 Days)
- ZYME 648.0K
- CCEC 11.9K
- Earning Date
- ZYME 10-30-2025
- CCEC 11-07-2025
- Dividend Yield
- ZYME N/A
- CCEC 5.29%
- EPS Growth
- ZYME N/A
- CCEC 62.73
- EPS
- ZYME N/A
- CCEC 4.04
- Revenue
- ZYME $122,867,000.00
- CCEC $424,701,000.00
- Revenue This Year
- ZYME $107.76
- CCEC $17.10
- Revenue Next Year
- ZYME $2.35
- CCEC $13.73
- P/E Ratio
- ZYME N/A
- CCEC $5.62
- Revenue Growth
- ZYME 95.94
- CCEC 84.28
- 52 Week Low
- ZYME $9.03
- CCEC $14.09
- 52 Week High
- ZYME $17.70
- CCEC $24.83
- Technical
- Relative Strength Index (RSI)
- ZYME 57.31
- CCEC 52.20
- Support Level
- ZYME $16.75
- CCEC $21.21
- Resistance Level
- ZYME $17.40
- CCEC $22.48
- Average True Range (ATR)
- ZYME 0.58
- CCEC 0.90
- MACD
- ZYME -0.06
- CCEC 0.02
- Stochastic Oscillator
- ZYME 38.20
- CCEC 59.46
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.